Citation:Kantor ED, Onstad L, Blount PL, Reid BJ, Vaughan TL 2012

From Clinical Guidelines Wiki

Citation


Kantor ED, Onstad L, Blount PL, Reid BJ, Vaughan TL. Use of statin medications and risk of esophageal adenocarcinoma in persons with Barrett's esophagus. Cancer Epidemiol Biomarkers Prev 2012 Mar;21(3):456-61 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/22241250.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
Are there any treatments that prevent progression of BO to cancer?Professor David Watson MBBS, MD, FRACScompleted
What are the risk factors for progression from non-dysplastic BO to high-grade dysplasia or adenocarcinoma?Professor David Whiteman B Med Sci, MBBS (Hons) PhD FAFPHMcompleted
Are there groups of patients with non-dysplastic BO that require more frequent surveillance?Dr Henry Tocompleted
Are there groups of patients with BO that can be discharged from surveillance?Conjoint Associate Professor Philip Craigcompleted

Compare quality appraisals for each clinical question

Cited by

  1. What are the risk factors for progression from non-dysplastic BO to high-grade dysplasia or adenocarcinoma?